Warning: The NCBI web site requires JavaScript to function. more...
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer.
Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, Lee KA, Ye S, Hyun H, Kang KN, Yeo D, Kim Y, Ohn SY, Noh DY, Kim CW.
Breast Cancer Res. 2009;11(2):R22. Epub 2009 Apr 28.
Related citations
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW.
Clin Chem. 2002 Aug;48(8):1296-304.
A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
Lee HJ, Kim YT, Park PJ, Shin YS, Kang KN, Kim Y, Kim CW.
J Thorac Cardiovasc Surg. 2012 Feb;143(2):421-427.e3. Epub 2011 Nov 20.
Autoantibodies as potential biomarkers for breast cancer.
Zhong L, Ge K, Zu JC, Zhao LH, Shen WK, Wang JF, Zhang XG, Gao X, Hu W, Yen Y, Kernstine KH.
Breast Cancer Res. 2008;10(3):R40. Epub 2008 May 7.
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer.
Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaften-Day C, Hacker NF, de Bruijn HW, van der Zee AG, Jacobs IJ, Fung ET, Chan DW.
Cancer Res. 2004 Aug 15;64(16):5882-90.
Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreira JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE.
Mol Oncol. 2010 Feb;4(1):65-89. Epub 2009 Nov 23.
Highly sensitive detection of melanoma based on serum proteomic profiling.
Caron J, Mangé A, Guillot B, Solassol J.
J Cancer Res Clin Oncol. 2009 Sep;135(9):1257-64. Epub 2009 Mar 14.
[Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].
Hu Y, Zhang SZ, Yu JK, Liu J, Zheng S, Hu X.
Ai Zheng. 2005 Jan;24(1):67-71. Chinese.
Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, Feliberti EC, Perry RR, Drake RR.
J Am Coll Surg. 2009 May;208(5):970-8; discussion 978-80. Epub 2009 Mar 26.
[Proteome analysis for identification of tumor-associated biomarkers in breast cancer].
Wang X, Liang WJ, Zhu ZY, Yang MT, Zeng YX.
Ai Zheng. 2004 Nov;23(11 Suppl):1577-81. Chinese.
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.
Belluco C, Petricoin EF, Mammano E, Facchiano F, Ross-Rucker S, Nitti D, Di Maggio C, Liu C, Lise M, Liotta LA, Whiteley G.
Ann Surg Oncol. 2007 Sep;14(9):2470-6. Epub 2007 Jun 27.
Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.
Sheu CC, Yu YP, Tsai JR, Chang MY, Lin SR, Hwang JJ, Chong IW.
Int J Cancer. 2006 Sep 15;119(6):1419-26.
Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL.
Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):102-7.
Clinical proteomics in breast cancer: a review.
Gast MC, Schellens JH, Beijnen JH.
Breast Cancer Res Treat. 2009 Jul;116(1):17-29. Epub 2008 Dec 11. Review.
Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI.
PLoS One. 2008;3(11):e3661. Epub 2008 Nov 6. Erratum in: PLoS ONE. 2009;4(1). doi: 10.1371/annotation/9fbf88b3-5041-4a5e-b569-bc6c0e5f9c29. Pospisil, Pavel [added].
Serum peptide profiling: identifying novel cancer biomarkers for early disease detection.
Martorella A, Robbins R.
Acta Biomed. 2007;78 Suppl 1:123-8.
[Biomarkers in breast cancer].
Kurebayashi J.
Gan To Kagaku Ryoho. 2004 Jul;31(7):1021-6. Review. Japanese.
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
Fredriksson S, Horecka J, Brustugun OT, Schlingemann J, Koong AC, Tibshirani R, Davis RW.
Clin Chem. 2008 Mar;54(3):582-9. Epub 2008 Jan 2.
Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
Nam H, Chung BC, Kim Y, Lee K, Lee D.
Bioinformatics. 2009 Dec 1;25(23):3151-7. Epub 2009 Sep 25.
Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models.
Hwa HL, Kuo WH, Chang LY, Wang MY, Tung TH, Chang KJ, Hsieh FJ.
J Eval Clin Pract. 2008 Apr;14(2):275-80. Epub 2008 Feb 18.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on